Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer.

Autor: Liu, Zaoqu1,2,3 (AUTHOR), Lu, Taoyuan4 (AUTHOR), Li, Jing1,2,3 (AUTHOR), Wang, Libo5 (AUTHOR), Xu, Kaihao1 (AUTHOR), Dang, Qin6 (AUTHOR), Guo, Chunguang7 (AUTHOR), Liu, Long5 (AUTHOR), Jiao, Dechao1 (AUTHOR), Sun, Zhenqiang6 (AUTHOR) fccsunzq@zzu.edu.cn, Han, Xinwei1,2,3 (AUTHOR) fcchanxw@zzu.edu.cn
Zdroj: Cancer Cell International. 7/7/2021, Vol. 21 Issue 1, p1-12. 12p.
Databáze: Academic Search Ultimate